LLY vs CAH
By Alex · Tickerpine
Eli Lilly and Company vs Cardinal Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | CAH |
|---|---|---|
| Price | $1,233.66 | $237.92 |
| Market cap | $1.10T | $55.33B |
| P/E ratio | 41.8 | 32.9 |
| ROE | 102.29% | — |
| Profit margin | 33.53% | 0.67% |
| Revenue growth | 47.70% | 5.80% |
| Dividend yield | 0.55% | 0.89% |
| Beta | 0.51 | 0.52 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs CAH in plain English
- LLY is the bigger company — about 19.9× the market cap of CAH.
- CAH is cheaper on earnings (P/E 32.9 vs 41.8).
- LLY is growing revenue faster (48% vs 6%).
- CAH has the higher dividend yield (0.89% vs 0.55%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
CAH return calculator
See what $1,000 in Cardinal Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.